Show simple item record

dc.contributor.authorVyse, S
dc.contributor.authorDesmond, H
dc.contributor.authorHuang, PH
dc.date.accessioned2017-03-01T12:55:39Z
dc.date.issued2017-02-23
dc.identifier.citationIUCrJ, 2017, 4 (Pt 2), pp. 119 - 130
dc.identifier.issn2052-2525
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/451
dc.identifier.eissn2052-2525
dc.identifier.doi10.1107/s2052252516020546
dc.description.abstractReceptor tyrosine kinases (RTKs) are key transmembrane environmental sensors that are capable of transmitting extracellular information into phenotypic responses, including cell proliferation, survival and metabolism. Advances in mass spectrometry (MS)-based phosphoproteomics have been instrumental in providing the foundations of much of our current understanding of RTK signalling networks and activation dynamics. Furthermore, new insights relating to the deregulation of RTKs in disease, for instance receptor co-activation and kinome reprogramming, have largely been identified using phosphoproteomic-based strategies. This review outlines the current approaches employed in phosphoproteomic workflows, including phosphopeptide enrichment and MS data-acquisition methods. Here, recent advances in the application of MS-based phosphoproteomics to bridge critical gaps in our knowledge of RTK signalling are focused on. The current limitations of the technology are discussed and emerging areas such as computational modelling, high-throughput phospho-proteomic workflows and next-generation single-cell approaches to further our understanding in new areas of RTK biology are highlighted.
dc.formatElectronic-eCollection
dc.format.extent119 - 130
dc.languageeng
dc.language.isoeng
dc.publisherINT UNION CRYSTALLOGRAPHY
dc.rights.urihttps://creativecommons.org/licenses/by/4.0
dc.titleAdvances in mass spectrometry based strategies to study receptor tyrosine kinases.
dc.typeJournal Article
dcterms.dateAccepted2016-12-27
rioxxterms.versionofrecord10.1107/s2052252516020546
rioxxterms.licenseref.urihttps://creativecommons.org/licenses/by/4.0
rioxxterms.licenseref.startdate2017-03
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfIUCrJ
pubs.issuePt 2
pubs.notesNo embargo
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Biology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Biology/Protein Networks
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology/Molecular and Systems Oncology
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Biology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Biology/Protein Networks
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology/Molecular and Systems Oncology
pubs.publication-statusPublished
pubs.volume4
pubs.embargo.termsNo embargo
icr.researchteamProtein Networks
icr.researchteamMolecular and Systems Oncology
dc.contributor.icrauthorHuang, Paul


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record

https://creativecommons.org/licenses/by/4.0
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0